Nuwellis NUWE
NASDAQ NUWE
$5.53 +0.24 (+4.54%)
At close: Nov 11, 2026 · 4:00 PM EST

Nuwellis (NUWE) Gains from Sales and Divestitures (2012 - 2020)

Updated

Nuwellis (NUWE) reported Gains from Sales and Divestitures of -$99,000 for FY2024.

Analysis

Nuwellis (NUWE) Gains from Sales and Divestitures (2012 - 2020) Analysis & Trends

  • The FY2024 figure ranks as the highest annual Gains from Sales and Divestitures since FY2020.
  • According to Business Quant data, Gains from Sales and Divestitures came in at -$40,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Nuwellis 105,523.12 -10.08 Mn 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 6,000.00
Mar 31, 2020 -46,000.00
Mar 31, 2012 -63,000.00
API Access

Nuwellis Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NUWE&period=max&api_key=YOUR_API_KEY